It confirmed a diagnosis of hypereosinophilic syndrome with the FIP1L1‐PDGFRA fusion gene, indicating myeloid neoplasm with eosinophilia and PDGFR-A rearrangement. This evidence concerns the gene PDGFRA and Increased total eosinophil count.